Bumper Offer - Urjas oil Just @ Rs. 1
Zifi 200 Tablet (10) is a prescription drug, available for use as Tablet. It is typically used for the treatment of Ear Infection, Tonsillitis, Bronchitis. Secondary and off-label uses of Zifi 200 Tablet (10) have also been mentioned below.
The right dosage of Zifi 200 Tablet (10) depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Zifi 200 Tablet (10) side effects, there are can be others also. These have been listed below. These side effects of Zifi 200 Tablet (10) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Zifi 200 Tablet (10) has a Safe effect for pregnant women and Safe effect on lactating mothers. In addition, Zifi 200 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Zifi 200 Tablet (10) related warnings section.
The section on Zifi 200 Tablet (10) contraindications lists all such conditions.
Besides this, Zifi 200 Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Zifi 200 Tablet (10) is not safe while driving, and is is not addictive in nature.
Zifi 200 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Female) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Zifi 200 Tablet (10) is used -
Severe
Mild
Is the use of Zifi 200 Tablet (10) safe for pregnant women?
Zifi is safe to take during pregnancy.
Is the use of Zifi 200 Tablet (10) safe during breastfeeding?
Zifi is completely safe for breastfeeding women.
What is the effect of Zifi 200 Tablet (10) on the Kidneys?
Zifi has very mild side effects on the kidneys.
What is the effect of Zifi 200 Tablet (10) on the Liver?
Zifi is not harmful for the liver.
What is the effect of Zifi 200 Tablet (10) on the Heart?
You can take Zifi without any fear of damage to the heart.
Zifi 200 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zifi 200 Tablet (10) unless your doctor advises you to do so -
Is this Zifi 200 Tablet (10) habit forming or addictive?
No, you will not get addicted to Zifi 200 Tablet (10).
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Zifi 200 Tablet (10) as you may feel sleepy.
Is it safe?
Zifi 200 Tablet (10) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Zifi 200 Tablet (10) in mental disorders is not effective.
Interaction between Food and Zifi 200 Tablet (10)
Taking Zifi 200 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Zifi 200 Tablet (10)
It is difficult to say anything about the effect of Zifi 200 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
